Showing results (411-420 of 895) with videos related to
Sort By:
Pageof 90
Drugs in R&D|November 9, 2005
Antidepressant drug-drug interaction profile updateLarry Ereshefsky, Stanford Jhee, Dale GrotheDrugs in R&D|November 9, 2005
Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activityReyes Corcóstegui, Luis Labeaga, Ana Innerárity, et al.Drugs in R&D|September 15, 2016
A Tailored Approach to the Treatment of a Patient with a Severe Dynamic Manifestation of Rosacea: A Case ReportMartin Schaller, Lena GonserDrugs in R&D|April 20, 2018
A Phase I Study of the Pharmacokinetics and Pharmacodynamics of Intranasal Doxylamine in Subjects with Chronic Intermittent Sleep ImpairmentMark Allison, Cecilia HaleDrugs in R&D|June 2, 2018
Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy VolunteersMarie Cullberg, Cecilia Arfvidsson, Bengt Larsson, et al.Drugs in R&D|March 7, 2015
Effect of a modified saquinavir/ritonavir dosing regimen with lower dose lead-in phase on QTc interval, pharmacokinetics, antiviral activity and safety in treatment-naïve HIV-1-infected patientsMarta Boffito, Akil Jackson, Anton Pozniak, et al.Drugs in R&D|June 28, 2020
Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host CellsMirza S Baig, Manikandan Alagumuthu, Sajjan Rajpoot, et al.Drugs in R&D|May 15, 2023
A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics of Napabucasin Combined with Sorafenib in Japanese Patients with Unresectable Hepatocellular CarcinomaTakuji Okusaka, Manabu Morimoto, Yuichiro Eguchi, et al.Drugs in R&D|August 22, 2025
Bioequivalence Study of Two Formulations of Flunarizine Hydrochloride Capsules in Healthy Chinese Subjects Under Fasting and Fed ConditionsYinglin Yang, Jiejing Kai, Duo Lv, et al.Pageof 90